Ectopic expression of receptor tyrosine kinases (RTKs) has been proved to play a vital role in lung cancer, and recently, tyrosine kinase inhibitors targeting EGFR are hot spots of targeting therapy in variety of cancer types (22). This evidence concerns the gene EGFR and lung carcinoma.